Senseonics Holdings (SENS) Depreciation & Amortization (CF) (2015 - 2026)
Senseonics Holdings' (SENS) quarterly Depreciation & Amortization (CF) came in at $545000.0 in Q1 2026, up 41.93% year-on-year from $384000.0 in Q1 2025, and up 42.67% on a QoQ basis from $382000.0 in Q4 2025.
Senseonics Holdings (SENS) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $545000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 41.93% year-over-year to $545000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 1.01% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, up 2.51% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $545000.0, up from $382000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for SENS reached as high as $766000.0 in Q4 2024 and fell as low as $169000.0 in Q1 2024.
- Historically, Depreciation & Amortization (CF) has averaged $340823.5 across 5 years, with a median of $263000.0 in 2022.
- Across the five-year window, Depreciation & Amortization (CF) jumped 171.79% in 2023 and tumbled 50.13% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $234000.0 in 2022, then soared by 171.79% to $636000.0 in 2023, then advanced by 20.44% to $766000.0 in 2024, then slumped by 50.13% to $382000.0 in 2025, then jumped by 42.67% to $545000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $545000.0 in Q1 2026, $382000.0 in Q4 2025, and $376000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | 545,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 545,000.00 |
| Mar 31, 2026 | 545,000.00 |
| Dec 31, 2025 | 382,000.00 |
| Dec 31, 2025 | 382,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 370,000.00 |
| Jun 30, 2025 | 370,000.00 |
| Mar 31, 2025 | 384,000.00 |
| Mar 31, 2025 | 384,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Sep 30, 2024 | 196,000.00 |
| Sep 30, 2024 | 196,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Mar 31, 2024 | 169,000.00 |
| Mar 31, 2024 | 169,000.00 |
| Dec 31, 2023 | 636,000.00 |
| Dec 31, 2023 | 636,000.00 |